): Clinical Protocol and Data Management The Office of Clinical Research (OCR) is the established office within the Norris Cotton Cancer Center (NCCC) which supports clinical cancer research at Dartmouth. The OCR provides support for investigator-initiated trials (IIT), cooperative group trials (as an NCTN Lead Academic Participating Site [LAPS] and Full Member of ALLIANCE, NRG, and CITN), and corporate-sponsored studies. The mission of the OCR is to assist with the planning, conduct, and compliance of clinical trials, involving cancer treatments and care, and to provide regulatory support for cancer-related population science studies as well. The OCR assures the highest quality of research and adherence to relevant regulations by primary upfront coordination of the study and ongoing review of research compliance. The OCR is a service group within the NCCC to provide investigators support and study data management, as well as protocol development, monitoring for cooperative group studies, screening for potential research participants, and liaison with federal and industry sponsors and regulatory bodies. The OCR provides resource support to the NCCC Scientific Review Committee (i.e., the Clinical Cancer Research Committee [CCRC]), its Quality Improvement Committee, its Clinical Trials Order Set Committee, and its Data Safety Monitoring and Accrual Committee (DSMAC). The OCR has been active in NCI initiatives regarding time-to-activation projects (ADOPT), the Clinical Trial Reporting Program (CTRP), and, most recently, will be overseeing NCCC's receipt of the NCTN LAPS award. The OCR has a track record of piloting new endeavors for the research enterprise within the Dartmouth-Hitchcock Health system, as it supports the largest single research group in the parent organization. With regard to data safety, DSMAC is a chartered multidisciplinary committee charged with overseeing the monitoring of participant safety, the conduct and progress of research protocols, and the validity and integrity of the data of clinical trials at NCCC and its subsites that are not reviewed by another study-specific safety and data monitoring committee. DSMAC has the authority to require protocol amendments needed for subject safety, suspend study enrollment of study activities, or recommend study closure to NCCC's CCRC. NCCC internal monitoring assesses the PI, research team and OCR regulatory, data integrity, and pharmacy compliance for specific protocols. On an annual basis, a minimum of a 10% sample of the NCCC investigator-initiated, working group, and federally funded studies other than NCI cooperative group studies are audited. Industry sponsors are responsible for monitoring and auditing the studies NCCC investigators conduct on their behalf. Depending on the specifics of the protocol, adverse events are reported to the NCI/Sponsor, the FDA, DSMAC and the local IRB. The DSMAC and the IRB have the authority to suspend immediately accrual and protocol activities until concerns related to the severe adverse events are addressed. The NCCC CCRC and the IRB have the authority to close a study immediately due to an unacceptable level of risk to study subjects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-40
Application #
9616824
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shee, Kevin; Jiang, Amanda; Varn, Frederick S et al. (2018) Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J :fj201801241R
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract. Aging Cell 17:e12733
Shajani-Yi, Zahra; de Abreu, Francine B; Peterson, Jason D et al. (2018) Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia 20:256-262
Szczepiorkowski, Zbigniew M; Burnett, Christine A; Dumont, Larry J et al. (2018) Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems. Transfusion 58:943-950
Bossé, Yohan; Amos, Christopher I (2018) A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27:363-379
Pande, Mala; Joon, Aron; Brewster, Abenaa M et al. (2018) Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13:e0196245
Smith, T Jarrod; Sondermann, Holger; O'Toole, George A (2018) Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces. ACS Synth Biol 7:2612-2617
Gorlova, Olga Y; Li, Yafang; Gorlov, Ivan et al. (2018) Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One 13:e0189498
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Cai, Yunliang; Wu, Shaoju; Zhao, Wei et al. (2018) Concussion classification via deep learning using whole-brain white matter fiber strains. PLoS One 13:e0197992

Showing the most recent 10 out of 1911 publications